FindTrial
Sign In

Study on expression of TIPE2 in bladder urothelial carcinoma

Study on expression of TIPE2 in bladder urothelial carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100053596
Enrollment
Unknown
Registered
2021-11-24
Start date
2021-11-22
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder cancer

Interventions

case series:None

Sponsors

The Second Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 90 Years

Inclusion criteria

Inclusion criteria: The pathological specimens and clinical data of 110 cases of bladder urothelial carcinoma who underwent radical cystectomy have been completed in our hospital.

Exclusion criteria

Exclusion criteria: Combined with other urinary tract tumors who received systemic chemotherapy or radiotherapy before surgery.

Design outcomes

Primary

MeasureTime frame
Immunohistochemistry;Clinical indicators;—

Countries

China

Contacts

Public ContactWang Yi

The Second Affiliated Hospital of Anhui Medical University

hbyiwang@126.com+86 18905690669

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026